ROYAL BANK OF CANADA - KALA PHARMACEUTICALS INC ownership

KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 64 filers reported holding KALA PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
ROYAL BANK OF CANADA ownership history of KALA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$01,597
+27.9%
0.00%
Q2 2022$0
-100.0%
1,249
-68.9%
0.00%
Q1 2022$5,000
-64.3%
4,021
-63.8%
0.00%
Q4 2021$14,000
-17.6%
11,101
+73.8%
0.00%
Q3 2021$17,000
-32.0%
6,386
+42.0%
0.00%
Q2 2021$25,000
-3.8%
4,497
+13.1%
0.00%
Q1 2021$26,000
+62.5%
3,975
+73.5%
0.00%
Q4 2020$16,000
+433.3%
2,291
+420.7%
0.00%
Q3 2020$3,000
-76.9%
440
-63.6%
0.00%
Q2 2020$13,000
+550.0%
1,208
+325.4%
0.00%
Q1 2020$2,000
-60.0%
284
-76.6%
0.00%
Q4 2019$5,000
+400.0%
1,213
+500.5%
0.00%
Q3 2019$1,000
-87.5%
202
-83.8%
0.00%
Q2 2019$8,000
+700.0%
1,250
+681.2%
0.00%
Q1 2019$1,0000.0%160
+6.7%
0.00%
Q4 2018$1,000
-66.7%
150
-57.5%
0.00%
Q3 2018$3,000
+50.0%
353
+135.3%
0.00%
Q2 2018$2,000
-90.0%
150
-88.0%
0.00%
Q1 2018$20,000
+900.0%
1,254
+1117.5%
0.00%
Q4 2017$2,000
-88.2%
103
-85.9%
0.00%
Q3 2017$17,0007310.00%
Other shareholders
KALA PHARMACEUTICALS INC shareholders Q4 2017
NameSharesValueWeighting ↓
Vahanian & Associates Financial Planning Inc. 1,046,484$1,266,0001.02%
RA Capital Management 10,874,613$13,158,0000.23%
Samsara BioCapital, LLC 601,162$727,0000.14%
Matisse Capital 41,400$50,0000.04%
Manteio Capital LLC 19,546$24,0000.03%
Covestor Ltd 17,766$21,0000.03%
Knights of Columbus Asset Advisors LLC 241,857$293,0000.02%
Virtu Financial LLC 126,231$153,0000.02%
Aquatic Capital Management LLC 6,200$8,0000.02%
CAXTON CORP 13,155$16,0000.01%
View complete list of KALA PHARMACEUTICALS INC shareholders